✦ LIBER ✦

1941 5 α REDUCTASE INHIBITORS AND RISK OF PROSTATE CANCER. NATION-WIDE, POPULATION-BASED CASE-CONTROL STUDY

✍ Scribed by Robinson, David; Garmo, Hans; Bill-Axelson, Anna; Lorelei, Lorelei; Holmberg, Lars; Stattin, Pär

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Use of 5α-reductase inhibitors for lower

✍ Andriole, G.L. 📂 Article 📅 2014 🏛 Elsevier Science ⚖ 53 KB

FINASTERIDE, α-BLOCKERS AND RISK OF PROS

✍ Murtola, T.; Tammela, T.; Määttänen, L.; Hakama, M.; Auvinen, A. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 64 KB

157 LONG-TERM OUTCOMES ACCORDING TO RISK

✍ Rider, Jennifer; Sandin, Fredrik; Fall, Katja; Stattin, Pär 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 141 KB

Risk of localized and advanced prostate

✍ Stacy Loeb, Linda Drevin, David Robinson, Erik Holmberg, Sigrid Carlsson, Mats L 📂 Article 📅 2012 🏛 Springer Netherlands 🌐 English ⚖ 247 KB

Proton Pump Inhibitor Use and Risk of Co

✍ Douglas J. Robertson; Heidi Larsson; Søren Friis; Lars Pedersen; John A. Baron; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 141 KB

Prostate cancer risk among users of fina

✍ Teemu J. Murtola; Teuvo L.J. Tammela; Liisa Määttänen; Matti Hakama; Anssi Auvin 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 161 KB